Skip to main content

Table 2 Summary table of answers to the multiresponse question “what was the most important reason to participate in a clinical trial?”, stratified per diagnostic group

From: Experiences of and recommendations on clinical trial design in Alzheimer’s disease from the participant’s point of view: a mixed-methods study in two clinical trial centers in the Netherlands

Most important reason to participate in a clinical trial

Overall

Alzheimer’s disease

Mild Cognitive impairment

Cognitively normal

N

% (ntotal=71)

n

% (nAD=33)

n

% (nMCI=19)

n

% (nCN=19)

For the future generation

63

88.7%

28

94.3%

17

98.5%

18

94.7%

For science

47

66.2%

21

63.6%

15

78.9%

11

57.9%

I think I will be monitored better

30

42.3%

14

91.5%

9

47.4%

7

36.8%

I find it interesting

22

31.0%

12

36.4%

162

39.7%

5

26.3%

My doctor recommended it

7

9.9%

5

15.2%

2

10.5%

0

0.0%

I think it is the best treatment

7

9.9%

5

15.2%

2

10.5%

0

0.0%

To receive better care

7

9.9%

4

12.1%

2

10.5%

1

5.3%

It is a useful time to spend the day

2

2.8%

2

6.1%

0

0.0%

0

0%